Synthesis and Bioevaluation of Iodine-131 Directly Labeled Cyclic RGD-PEGylated Gold Nanorods for Tumor-Targeted Imaging

Figure 4

Representative whole body SPECT/CT images of B16F10 (a), blocked B16F10 (b), and MCF-7 (c) tumor-bearing mice at 1, 3, 6, 9, and 12 h after intravenous injection of ¹³¹IGNR-PEG-cRGD. Arrows indicate tumor sites.

(a)

(b)

(c)